These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11589874)

  • 1. Tyrosinemia type II: nine cases of ocular signs and symptoms.
    Macsai MS; Schwartz TL; Hinkle D; Hummel MB; Mulhern MG; Rootman D
    Am J Ophthalmol; 2001 Oct; 132(4):522-7. PubMed ID: 11589874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tyrosinemia type II. Case report].
    Benatiya AI; Bouayed MA; Touiza E; Daoudi K; Bhalil S; Elmesbahi I; Tahri H
    Bull Soc Belge Ophtalmol; 2005; (296):57-61. PubMed ID: 16050420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion.
    Iskeleli G; Bilgeç MD; Arici C; Atalay E; Oğreden T; Aydin A
    Turk J Pediatr; 2011; 53(6):692-4. PubMed ID: 22389994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated corneal pseudodendrites as the initial manifestation of tyrosinemia type II in monozygotic twins.
    Kymionis GD; Kankariya VP; Kontadakis GA; Ziakas NG
    J Pediatr Ophthalmol Strabismus; 2012 May; 49 Online():e33-6. PubMed ID: 22588828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo confocal microscopic features of corneal pseudodendritic lesions in tyrosinemia type II.
    Kocabeyoglu S; Mocan MC; Irkec M
    Cornea; 2014 Oct; 33(10):1106-8. PubMed ID: 25119963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report.
    Valikhani M; Akhyani M; Jafari AK; Barzegari M; Toosi S
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):591-4. PubMed ID: 16684290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual dendritic keratitis.
    Gokhale NS; Dherai AJ; Desai H; Ashavaid TF
    Indian J Ophthalmol; 2007; 55(1):57-9. PubMed ID: 17189889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal Pseudodendritic Lesions Masquerading as Herpetic Keratitis in a Patient With Tyrosinemia Type I.
    Gulmez Sevim D; Gumus K; Cavanagh HD
    Eye Contact Lens; 2017 May; 43(3):e7-e9. PubMed ID: 26322918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal lesion as the initial manifestation of tyrosinemia type II.
    Tsai CP; Lin PY; Lee NC; Niu DM; Lee SM; Hsu WM
    J Chin Med Assoc; 2006 Jun; 69(6):286-8. PubMed ID: 16863017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
    al-Hemidan AI; al-Hazzaa SA
    Ophthalmic Genet; 1995 Mar; 16(1):21-6. PubMed ID: 7648039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome.
    Soares DC; Stroparo MN; Lian YC; Takakura CY; Wolf S; Betz R; Kim CA
    J Inherit Metab Dis; 2017 May; 40(3):461-462. PubMed ID: 27832414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
    Pelet B; Antener I; Faggioni R; Spahr A; Gautier E
    Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Richner-Hanhart syndrome (tyrosinemia II): early diagnosis of an incomplete presentation with unusual findings.
    Viglizzo GM; Occella C; Bleidl D; Rongioletti F
    Pediatr Dermatol; 2006; 23(3):259-61. PubMed ID: 16780475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incurable keratitis and chronic palmoplantar hyperkeratosis with hypertyrosinemia. Cure using a tyrosine-restricted diet. Type II tyrosinemia].
    Hervé F; Moreno JL; Ogier H; Saudubray JM; De Prost Y; Duffier JL; Charpentier C; Lemonnier F; Frézal J
    Arch Fr Pediatr; 1986 Jan; 43(1):19-22. PubMed ID: 2939812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral dendriform ulcer leading to an early diagnosis of tyrosinemia type 2.
    Martin GC; de Lonlay P; Chapron T; Cochereau I; Caputo G; Gabison E
    J AAPOS; 2020 Apr; 24(2):120-122. PubMed ID: 32018000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and intellectual functioning in patients with tyrosinemia type I.
    Pohorecka M; Biernacka M; Jakubowska-Winecka A; Biernacki M; Kuśmierska K; Kowalik A; Sykut-Cegielska J
    Pediatr Endocrinol Diabetes Metab; 2012; 18(3):96-100. PubMed ID: 23146787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Richner-Hanhart syndrome (tyrosinemia type II).
    Locatelli F; Puzenat E; Arnoux JB; Blanc D; Aubin F
    Cutis; 2017 Dec; 100(6):E20-E22. PubMed ID: 29360903
    [No Abstract]   [Full Text] [Related]  

  • 18. Dietary management of oculocutaneous tyrosinemia in an 11-year-old child.
    Ney D; Bay C; Schneider JA; Kelts D; Nyhan WL
    Am J Dis Child; 1983 Oct; 137(10):995-1000. PubMed ID: 6225330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosinemia: a report of three cases from India.
    Shah I
    Indian J Gastroenterol; 2013 Mar; 32(2):123-6. PubMed ID: 23408258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudodendritic keratitis and systemic tyrosinemia.
    Charlton KH; Binder PS; Wozniak L; Digby DJ
    Ophthalmology; 1981 Apr; 88(4):355-60. PubMed ID: 6454871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.